Weis et al., “Statins Have Biphasic Effects On Angiogenesis” (2002) Circulation, 105(6), 739-745, Database CAPLUS, AN 2002:212119.* |
Weis et al., “Statins Have Biphasic Effects On Angiogenesis” (2001a) Eur.Heart J., 22, Abstr. Suppl., 485, in Database DRUGU P, AN 2002-06077.* |
Weis et al., “HMG-CoA Reductase Inhibition Has Biphasic Effects On Angiogenesis” (2001b) Circulation, 104, No. 17, Suppl., 124, in Database DRUGU P, AN 2002-09924.* |
Kong et al., “HMG-CoA Reductase Inhibitors Interfere With VEGF Signaling In Human Endothelial Cells” (2000) Circulation, 102, No. 18, Suppl., 64, in Database DRUGU P, AN 2001-07231.* |
Kong et al., “The Anti-Angiogenic Effects Of HMG CoA Reductase Inhibitors: A New Role For RhoA GTPase In The Regulation Of Angiogenesis” (1999) Circulation, 100, No. 18, Suppl., 39, Abst. 194.* |
Carmen et al., “Double-Edged Role Of Statins In Angiogenesis Signaling” (2002) Circulation Research, 90 (6) 737-44, in Database IN-PROCESS, AN 2002201902.* |
Anon., “Product news: Is angiogenesis another effect of the statins?” INPHARMA Oct. 12, 2000, in Database ADISNEWS, AN 2000:2406.* |
Y. Kureishi, et al., “The HMH-CoA Reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.” Nature Medicine vol. 6: No. 8, pp 1004-1010 Sep. 2000. |
International Search Report for PCT/US01/18175. |